Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"the private equity firm GEM, allows us to place shares with them at a pre-designed price mechanism that is based on the weighted average stock price."
Who do you think want this lower?....obviously the PE Firm GEM!
IMO...as I said several days ago...
The Swiss market sold off several days ago down to $.15 That should have raised a red flag that a Major Secondary at a very low offering was coming...very soon.
This company had on its book only $126K in cash when it started its run from $.05 to $.94. Where is it going on that?...IMO nowhere without raising millions and it wont be done without significant dilution in an already diluted company.
There is a reason why Swiss market sells off everyday...
Price discovery is occurring...and forcing SP down (those secondary market buyers/financiers want a bargain too!
IMO watch for much lower price and big dilution...
It better have outstanding news when it announces the secondary...or else you will likely see .20
LOL...I only posted re: speculating on the drop...AFTER the Drop! Take a big breath!
So why do you believe it dropped?
NO ONE WANTS TO COME UP WITH A REASONABLE EXPLANATION...outside of "the boogie man did it."
My guess is an big secondary and/or manor reverse split, or both. BUT AGAIN...just a guess.
...where are the lies? Tell the board the possible reasons for the drop!
...lol...so wrong.
you already know...
Never claimed to have knowledge...Clearly speculating on possible explanations and causes.
You have better possible reason for the drop?
I have another...perhaps a major reverse split to be announced. (not necessarily the worst thing in the world...depending on the end game.)
PS. with SP going lower...IMO a secondary is coming...and possibly much lower than .40 from where pre-open is at.
Yes opinion on what "could have caused" the drop. Do you have better possible explanations why?
Never claimed to have "knowledge" of why. I am speculating based on experience in the market.
So, tell the board why it dropped?
Yes opinion on what "could have caused" the drop. Do you have better possible explanations why? If so, tell me why it dropped?
I am not soft bashing...it's not (IMO), as represented by some here, to be the only or best game in town... just pointing out that there is "another" that will prove to be more dynamic.
Meanwhile...go for it, but I would (and am) cautious for the reason's outlined.
Where are the lies? Suggesting reason for the drop. Do you have better ones?
Live Human Lung and Liver tissues...by two independent U.S. gov Labs...from which results came. Other indications passed for Phase I Safety...with over 500 patients.
read all of press release referred to in 4287 post..."Destruction" = "non-replication" it cant multiply when destroyed...it doesn't "disable" or "impede"...it "Destoys" ... a more effective result.
# Arranging and announcement of a Major Secondary Financing below $.40 (did the CEO know about that too? Of course he did)
At this point it looks like and is more likely being driven by a Secondary being offered at .40 or below. $ for trials?
...I laid out possible reasons for drop...that is all. Deal with it.
Tell the board why it dropped!
B.... by 3 to 1 will outstrip Aviptadil...with its 3 in 1 combination...as it DESTROYS the Viral Cells (anti-viral)...it also specifically inhibits pro-inflammatory cytokines and chemokines (anti-inflammatory) while is also antimicrobial (anti-bacterial for secondary infections).
Press Release May 26, 2020 - ...receiving data from a leading Public Health Research Institute (PHRI) showing B........ inhibits SARS-CoV-2, the novel coronavirus responsible for COVID-19, in a human cell line:
"Additional pre-clinical and clinical data support B...... potential to inhibit the production of IL-6, IL-1ß, TNF-a and other pro-inflammatory cytokines and chemokines (MCP-1), which have been identified as central drivers in the worsening prognoses of COVID-19 patients. B..... antimicrobial properties might also help to fight secondary bacterial infections, which can co-present in up to 20 percent of COVID-19 patients. These data collectively support Brilacidin as a particularly promising and unique (3 in 1 combination: antiviral, immune/anti-inflammatory, and antimicrobial) anti-COVID-19 therapeutic candidate."
August 3 press release:
“No other antiviral agent has demonstrated rapid recovery from viral infection and demonstrated laboratory inhibition of viral replication,”
Where did I ever say I did? I am not even critical of the progress it has made. I am critical of CEO saying that no other drug can do XYZ...when the fact is...others can.
WRONG...Insiders cannot just sell when they want to... they are restricted and especially so when they send out "Promo" Prs and dump into them. Many red flags for the S.E.C. Whether that is the issue or more dilution via financing lining up ... anyone's guess until company makes a statement.
...nice try...Panic has already set in... I am just asking "what caused it" and identifying some possible reasons...
DO YOU KNOW WHY this dropped like a lead balloon?
...this will greatly affect the Share Price RLFTF will be able to solite for financing trials.
It could be a cram-down by potential financing partner...since pricing of shares sold to Banker is usually based upon the last 3 days before agreement is signed. They would want to get "cheap" shares too...lol
...making statements that "no other drugs" can do this...IS "the false statement"...has nothing to do with negating what Relief's candidate can do...but those statements are false...others do the same and at least "one" is proving have the potential of a lot more...
...what does that have with CEO putting out press releases and selling into the rise? One is a Science issue, the other a Regulatory issue...
Good science doesn't waive compliance with S.E.C.Regulations and enforcement
...its not the dollar amount that is important or determinative...its the PROMOTING SP via PRs and then selling shares at the same time...S.E.C. will look at it as pure Stock Manipulation and Insider trading by CEO.
The greater danger to the stock is banning the CEO from holding an executive position in a public company...it could result in his becoming a "consultant" to the company without any decision making authority.
...it has nothing to do with the $ amount...if that is the issue causing the drop...the SEC would look at an Insider Selling at the same time Hyping and Promoting stock and "potential" revenue. A huge No-No.= Stock Manipulation
...yes a very stupid move...esp. Putting out statement and misrepresentations regarding "efficacy" and falsely stating that competitors did not have...when in fact they do!
"we might be able to sell off in the .4 s and even if we bought back in the .3 s and paid capital gains"
you have been holding over 1 year?...otherwise NO Capital Gains treatment. It is treated as Ordinary Income.
...hardly
there is an issue...could be FDA/FTC sanctioning CEO for false statements in promo PRs.
IMO...all will know before the open.
...the "real" news will guide you...Something from the company will likely come out before the open.
...also margin calls if this doesn't recover in three days (by Friday)
...the S.E.C.
reporting...delayed
slightly more than $1M in value...stock traded between $.60-.80 that day and over 2M shares dumped...
Problem is likely CEO very promotional and was putting out press releases regarding Sales etc...Hyping at the same time selling.
Deja vu....Kodak?
IMO...MC over inflated... drop had to come.
Could also be announcement of Russia approving a vaccine...(big deal?) but market up ... drives down all Covid-19 prospects?
...actually they have not yet done a direct comparison....and no guarantee they will...
...what they are doing is establishing new data to support the mechanisms that creates the efficacies of the drug...
...that data and effectiveness will in and of itself support comparisons to any and all other proposed therapeutics.
you state:
Its not the same technology...has no relevancy to where IPIX is going...
why?... wait for news from RBL...then you will likely be saying that...
...sounds like a "peaceful protester" to me!
...so called "Competition" is not Competition...but place-cards for Brilacidin to show them how a real Therapeutic is intended to work.
When it comes out to be "far superior"...the others will naturally drop by the wayside and be forgotten.